DTE
75
3
MMC
64
-3
GLW
52
3
NTAP
54
2
OXY
34
2
EXPD
42
15
KLAC
61
-2
CCI
25
-3
AMGN
26
-4
IR
40
-7
HSIC
50
2
EXR
48
-2
F
48
6
INTC
47
4
GM
29
2
WDC
41
3
SLB
55
2
MNST
59
2
KEY
39
6
KIM
48
-6
DTE
75
3
MMC
64
-3
GLW
52
3
NTAP
54
2
OXY
34
2
EXPD
42
15
KLAC
61
-2
CCI
25
-3
AMGN
26
-4
IR
40
-7
HSIC
50
2
EXR
48
-2
F
48
6
INTC
47
4
GM
29
2
WDC
41
3
SLB
55
2
MNST
59
2
KEY
39
6
KIM
48
-6
Financhill
Back

Preformed Line Products Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

PLPC
Preformed Line Products

Last Price:
$140.54
Seasonality Move:
0.86%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.14
Seasonality Move:
1.75%
Sell
47
Preformed Line Products (PLPC) is a Sell

Is Preformed Line Products a Buy, Sell or Hold?

  • The current Preformed Line Products [PLPC] share price is $140.73. The Score for PLPC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PLPC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLPC Stock Price Chart

What is Preformed Line Products's stock price today?

  • The Preformed Line Products share price today is $140.73
    The current trend is moderately bullish and PLPC is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

PLPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.93 Buy
Relative Strength Index (14 RSI): 52.9 Buy
Chaikin Money Flow: -14720 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.76 - 146.58) Buy
Bollinger Bands (100): (123.7 - 139.16) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

PLPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 143.33 Sell
20-day SMA: 141 Sell
50-day SMA: 133.93 Buy
200-day SMA: 127.9 Buy
8-day EMA: 142.44 Sell
20-day EMA: 140.36 Buy
50-day EMA: 135.91 Buy
200-day EMA: 130.3 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Preformed Line Products Earnings Growth & PLPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Preformed Line Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):